ロード中...

Heparanase inhibitors restrain mesothelioma

Malignant mesothelioma is a highly aggressive form of cancer with poor prognosis due to lack of markers for early diagnosis and resistance to conventional therapies. Heparanase, the sole heparan sulfate (HS) degrading endoglycosidase, regulates multiple biological activities that enhance tumor growt...

詳細記述

保存先:
書誌詳細
出版年:Oncotarget
主要な著者: Lapidot, Moshe, Barash, Uri, Vlodavsky, Israel, Pass, Harvey
フォーマット: Artigo
言語:Inglês
出版事項: Impact Journals LLC 2018
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6305150/
https://ncbi.nlm.nih.gov/pubmed/30627323
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.26243
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!